Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by CincyTech
CORRECTING and REPLACING Kurome Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for KME-0584 for the Treatment of Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS)
February 15, 2024
From
CincyTech
Via
Business Wire
Eyas™ Medical Imaging Brings State-of-the-Art MRI to NICUs, Revolutionizing Access for Fragile Newborns
July 12, 2023
From
CincyTech
Via
Business Wire
Invirsa Completes $7.7M Series B Financing
June 14, 2023
From
CincyTech
Via
Business Wire
Kurome Therapeutics Announces Oral and Poster Presentations on Dual IRAK1/4 Inhibitors at American Society of Hematology Annual Meeting
December 06, 2022
From
CincyTech
Via
Business Wire
TeamCentral a ‘Virtual Assistant’ to the Workforce
April 27, 2022
From
CincyTech
Via
Business Wire
Hive Networks and International Rett Syndrome Foundation Partner to Advance Research and Treatment for Rett Syndrome
October 18, 2021
From
CincyTech
Via
Business Wire
Cordata and Cincinnati Children’s Launching Solution for Improving the Well-Being of Children in Foster Care
September 13, 2021
From
CincyTech
Via
Business Wire
Eikonoklastes Closes Oversubscribed Series A Financing, Helping to Advance Immunotherapies Toward Clinical Trial Stage
June 28, 2021
From
CincyTech
Via
Business Wire
Kurome Therapeutics Closes $15 Million Series A Financing to Develop Targeted Kinase Inhibitors for Treatment of Hematopoietic Cancers
June 10, 2021
From
CincyTech
Via
Business Wire
Abre.io Selected as Strategic Partner in Ohio
April 14, 2021
From
CincyTech
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.